Free Trial

GE HealthCare Technologies (GEHC) Competitors

GE HealthCare Technologies logo
$65.74 0.00 (0.00%)
Closing price 10/9/2026 04:00 PM Eastern
Extended Trading
$66.04 +0.30 (+0.45%)
As of 04:06 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

GEHC vs. PHG, MDT, SYK, BSX, and EW

Should you buy GE HealthCare Technologies stock or one of its competitors? GE HealthCare Technologies's main competitors and comparable companies include Koninklijke Philips (PHG), Medtronic (MDT), Stryker (SYK), Boston Scientific (BSX), and Edwards Lifesciences (EW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does GE HealthCare Technologies compare to Koninklijke Philips?

Koninklijke Philips (NYSE:PHG) and GE HealthCare Technologies (NASDAQ:GEHC) are both large-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, media sentiment, valuation, analyst recommendations, risk, institutional ownership, profitability and earnings.

GE HealthCare Technologies has a net margin of 9.33% compared to Koninklijke Philips' net margin of 6.30%. GE HealthCare Technologies' return on equity of 20.12% beat Koninklijke Philips' return on equity.

Company Net Margins Return on Equity Return on Assets
Koninklijke Philips6.30% 14.38% 5.96%
GE HealthCare Technologies 9.33%20.12%5.74%

GE HealthCare Technologies has higher revenue and earnings than Koninklijke Philips. GE HealthCare Technologies is trading at a lower price-to-earnings ratio than Koninklijke Philips, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Koninklijke Philips$20.17B1.18$1.01B$1.3617.81
GE HealthCare Technologies$20.63B1.44$2.08B$4.3615.08

Koninklijke Philips pays an annual dividend of $0.84 per share and has a dividend yield of 3.5%. GE HealthCare Technologies pays an annual dividend of $0.14 per share and has a dividend yield of 0.2%. Koninklijke Philips pays out 61.8% of its earnings in the form of a dividend. GE HealthCare Technologies pays out 3.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. GE HealthCare Technologies has increased its dividend for 1 consecutive years.

13.7% of Koninklijke Philips shares are held by institutional investors. Comparatively, 82.1% of GE HealthCare Technologies shares are held by institutional investors. 0.4% of GE HealthCare Technologies shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Koninklijke Philips has a beta of 0.77, meaning that its stock price is 23% less volatile than the broader market. Comparatively, GE HealthCare Technologies has a beta of 0.73, meaning that its stock price is 27% less volatile than the broader market.

In the previous week, GE HealthCare Technologies had 25 more articles in the media than Koninklijke Philips. MarketBeat recorded 29 mentions for GE HealthCare Technologies and 4 mentions for Koninklijke Philips. Koninklijke Philips' average media sentiment score of 0.77 beat GE HealthCare Technologies' score of 0.34 indicating that Koninklijke Philips is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Koninklijke Philips
1 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
GE HealthCare Technologies
4 Very Positive mention(s)
5 Positive mention(s)
15 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral

GE HealthCare Technologies has a consensus target price of $78.52, indicating a potential upside of 19.44%. Given GE HealthCare Technologies' stronger consensus rating and higher probable upside, analysts plainly believe GE HealthCare Technologies is more favorable than Koninklijke Philips.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Koninklijke Philips
0 Sell rating(s)
5 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
GE HealthCare Technologies
0 Sell rating(s)
10 Hold rating(s)
11 Buy rating(s)
1 Strong Buy rating(s)
2.59

Summary

GE HealthCare Technologies beats Koninklijke Philips on 15 of the 20 factors compared between the two stocks.

How does GE HealthCare Technologies compare to Medtronic?

Medtronic (NYSE:MDT) and GE HealthCare Technologies (NASDAQ:GEHC) are both large-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, dividends, media sentiment, valuation and analyst recommendations.

In the previous week, Medtronic had 16 more articles in the media than GE HealthCare Technologies. MarketBeat recorded 45 mentions for Medtronic and 29 mentions for GE HealthCare Technologies. Medtronic's average media sentiment score of 0.80 beat GE HealthCare Technologies' score of 0.34 indicating that Medtronic is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Medtronic
23 Very Positive mention(s)
6 Positive mention(s)
13 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
GE HealthCare Technologies
4 Very Positive mention(s)
5 Positive mention(s)
15 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral

Medtronic currently has a consensus price target of $102.92, suggesting a potential upside of 16.21%. GE HealthCare Technologies has a consensus price target of $78.52, suggesting a potential upside of 19.44%. Given GE HealthCare Technologies' higher probable upside, analysts clearly believe GE HealthCare Technologies is more favorable than Medtronic.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Medtronic
0 Sell rating(s)
10 Hold rating(s)
18 Buy rating(s)
0 Strong Buy rating(s)
2.64
GE HealthCare Technologies
0 Sell rating(s)
10 Hold rating(s)
11 Buy rating(s)
1 Strong Buy rating(s)
2.59

82.1% of Medtronic shares are owned by institutional investors. Comparatively, 82.1% of GE HealthCare Technologies shares are owned by institutional investors. 0.3% of Medtronic shares are owned by insiders. Comparatively, 0.4% of GE HealthCare Technologies shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Medtronic has a beta of 0.55, meaning that its share price is 45% less volatile than the broader market. Comparatively, GE HealthCare Technologies has a beta of 0.73, meaning that its share price is 27% less volatile than the broader market.

Medtronic pays an annual dividend of $2.88 per share and has a dividend yield of 3.3%. GE HealthCare Technologies pays an annual dividend of $0.14 per share and has a dividend yield of 0.2%. Medtronic pays out 70.9% of its earnings in the form of a dividend. GE HealthCare Technologies pays out 3.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Medtronic has increased its dividend for 49 consecutive years and GE HealthCare Technologies has increased its dividend for 1 consecutive years. Medtronic is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Medtronic has a net margin of 13.93% compared to GE HealthCare Technologies' net margin of 9.33%. GE HealthCare Technologies' return on equity of 20.12% beat Medtronic's return on equity.

Company Net Margins Return on Equity Return on Assets
Medtronic13.93% 14.78% 7.97%
GE HealthCare Technologies 9.33%20.12%5.74%

Medtronic has higher revenue and earnings than GE HealthCare Technologies. GE HealthCare Technologies is trading at a lower price-to-earnings ratio than Medtronic, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Medtronic$36.36B3.12$4.80B$4.0621.81
GE HealthCare Technologies$20.63B1.44$2.08B$4.3615.08

Summary

Medtronic beats GE HealthCare Technologies on 12 of the 19 factors compared between the two stocks.

How does GE HealthCare Technologies compare to Stryker?

GE HealthCare Technologies (NASDAQ:GEHC) and Stryker (NYSE:SYK) are both large-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, risk, earnings, profitability, valuation, analyst recommendations, institutional ownership and media sentiment.

GE HealthCare Technologies has a beta of 0.73, indicating that its share price is 27% less volatile than the broader market. Comparatively, Stryker has a beta of 0.78, indicating that its share price is 22% less volatile than the broader market.

GE HealthCare Technologies presently has a consensus target price of $78.52, indicating a potential upside of 19.44%. Stryker has a consensus target price of $370.68, indicating a potential upside of 33.69%. Given Stryker's stronger consensus rating and higher possible upside, analysts plainly believe Stryker is more favorable than GE HealthCare Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
GE HealthCare Technologies
0 Sell rating(s)
10 Hold rating(s)
11 Buy rating(s)
1 Strong Buy rating(s)
2.59
Stryker
0 Sell rating(s)
6 Hold rating(s)
17 Buy rating(s)
1 Strong Buy rating(s)
2.79

Stryker has higher revenue and earnings than GE HealthCare Technologies. GE HealthCare Technologies is trading at a lower price-to-earnings ratio than Stryker, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
GE HealthCare Technologies$20.63B1.44$2.08B$4.3615.08
Stryker$25.84B4.12$3.25B$9.6528.73

In the previous week, GE HealthCare Technologies had 6 more articles in the media than Stryker. MarketBeat recorded 29 mentions for GE HealthCare Technologies and 23 mentions for Stryker. GE HealthCare Technologies' average media sentiment score of 0.34 beat Stryker's score of 0.33 indicating that GE HealthCare Technologies is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
GE HealthCare Technologies
4 Very Positive mention(s)
5 Positive mention(s)
15 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral
Stryker
2 Very Positive mention(s)
6 Positive mention(s)
13 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

GE HealthCare Technologies pays an annual dividend of $0.14 per share and has a dividend yield of 0.2%. Stryker pays an annual dividend of $3.52 per share and has a dividend yield of 1.3%. GE HealthCare Technologies pays out 3.2% of its earnings in the form of a dividend. Stryker pays out 36.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. GE HealthCare Technologies has increased its dividend for 1 consecutive years and Stryker has increased its dividend for 32 consecutive years. Stryker is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

82.1% of GE HealthCare Technologies shares are held by institutional investors. Comparatively, 77.1% of Stryker shares are held by institutional investors. 0.4% of GE HealthCare Technologies shares are held by company insiders. Comparatively, 4.6% of Stryker shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Stryker has a net margin of 14.43% compared to GE HealthCare Technologies' net margin of 9.33%. Stryker's return on equity of 23.63% beat GE HealthCare Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
GE HealthCare Technologies9.33% 20.12% 5.74%
Stryker 14.43%23.63%11.39%

Summary

Stryker beats GE HealthCare Technologies on 15 of the 19 factors compared between the two stocks.

How does GE HealthCare Technologies compare to Boston Scientific?

GE HealthCare Technologies (NASDAQ:GEHC) and Boston Scientific (NYSE:BSX) are both large-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, media sentiment, risk, earnings, dividends, institutional ownership, profitability and valuation.

Boston Scientific has higher revenue and earnings than GE HealthCare Technologies. GE HealthCare Technologies is trading at a lower price-to-earnings ratio than Boston Scientific, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
GE HealthCare Technologies$20.63B1.44$2.08B$4.3615.08
Boston Scientific$21.00B2.95$2.90B$2.4717.29

Boston Scientific has a net margin of 17.50% compared to GE HealthCare Technologies' net margin of 9.33%. GE HealthCare Technologies' return on equity of 20.12% beat Boston Scientific's return on equity.

Company Net Margins Return on Equity Return on Assets
GE HealthCare Technologies9.33% 20.12% 5.74%
Boston Scientific 17.50%19.28%10.89%

GE HealthCare Technologies has a beta of 0.73, suggesting that its stock price is 27% less volatile than the broader market. Comparatively, Boston Scientific has a beta of 0.58, suggesting that its stock price is 42% less volatile than the broader market.

82.1% of GE HealthCare Technologies shares are owned by institutional investors. Comparatively, 89.1% of Boston Scientific shares are owned by institutional investors. 0.4% of GE HealthCare Technologies shares are owned by insiders. Comparatively, 0.3% of Boston Scientific shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

GE HealthCare Technologies currently has a consensus target price of $78.52, indicating a potential upside of 19.44%. Boston Scientific has a consensus target price of $66.31, indicating a potential upside of 55.25%. Given Boston Scientific's stronger consensus rating and higher probable upside, analysts clearly believe Boston Scientific is more favorable than GE HealthCare Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
GE HealthCare Technologies
0 Sell rating(s)
10 Hold rating(s)
11 Buy rating(s)
1 Strong Buy rating(s)
2.59
Boston Scientific
2 Sell rating(s)
6 Hold rating(s)
22 Buy rating(s)
0 Strong Buy rating(s)
2.67

In the previous week, GE HealthCare Technologies had 7 more articles in the media than Boston Scientific. MarketBeat recorded 29 mentions for GE HealthCare Technologies and 22 mentions for Boston Scientific. Boston Scientific's average media sentiment score of 0.39 beat GE HealthCare Technologies' score of 0.34 indicating that Boston Scientific is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
GE HealthCare Technologies
4 Very Positive mention(s)
5 Positive mention(s)
15 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral
Boston Scientific
6 Very Positive mention(s)
0 Positive mention(s)
10 Neutral mention(s)
4 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Boston Scientific beats GE HealthCare Technologies on 11 of the 17 factors compared between the two stocks.

How does GE HealthCare Technologies compare to Edwards Lifesciences?

Edwards Lifesciences (NYSE:EW) and GE HealthCare Technologies (NASDAQ:GEHC) are both large-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, profitability, dividends, analyst recommendations, valuation, institutional ownership, risk and media sentiment.

Edwards Lifesciences has a beta of 0.87, indicating that its share price is 13% less volatile than the broader market. Comparatively, GE HealthCare Technologies has a beta of 0.73, indicating that its share price is 27% less volatile than the broader market.

79.5% of Edwards Lifesciences shares are held by institutional investors. Comparatively, 82.1% of GE HealthCare Technologies shares are held by institutional investors. 0.3% of Edwards Lifesciences shares are held by company insiders. Comparatively, 0.4% of GE HealthCare Technologies shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Edwards Lifesciences has a net margin of 15.43% compared to GE HealthCare Technologies' net margin of 9.33%. GE HealthCare Technologies' return on equity of 20.12% beat Edwards Lifesciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Edwards Lifesciences15.43% 15.68% 12.05%
GE HealthCare Technologies 9.33%20.12%5.74%

GE HealthCare Technologies has higher revenue and earnings than Edwards Lifesciences. GE HealthCare Technologies is trading at a lower price-to-earnings ratio than Edwards Lifesciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Edwards Lifesciences$6.51B7.54$1.07B$1.7449.00
GE HealthCare Technologies$20.63B1.44$2.08B$4.3615.08

In the previous week, GE HealthCare Technologies had 15 more articles in the media than Edwards Lifesciences. MarketBeat recorded 29 mentions for GE HealthCare Technologies and 14 mentions for Edwards Lifesciences. Edwards Lifesciences' average media sentiment score of 0.44 beat GE HealthCare Technologies' score of 0.34 indicating that Edwards Lifesciences is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Edwards Lifesciences
4 Very Positive mention(s)
0 Positive mention(s)
7 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
GE HealthCare Technologies
4 Very Positive mention(s)
5 Positive mention(s)
15 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral

Edwards Lifesciences presently has a consensus target price of $100.27, indicating a potential upside of 17.60%. GE HealthCare Technologies has a consensus target price of $78.52, indicating a potential upside of 19.44%. Given GE HealthCare Technologies' higher possible upside, analysts clearly believe GE HealthCare Technologies is more favorable than Edwards Lifesciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Edwards Lifesciences
0 Sell rating(s)
5 Hold rating(s)
16 Buy rating(s)
1 Strong Buy rating(s)
2.82
GE HealthCare Technologies
0 Sell rating(s)
10 Hold rating(s)
11 Buy rating(s)
1 Strong Buy rating(s)
2.59

Summary

Edwards Lifesciences and GE HealthCare Technologies tied by winning 8 of the 16 factors compared between the two stocks.

Get GE HealthCare Technologies News Delivered to You Automatically

Sign up to receive the latest news and ratings for GEHC and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding GEHC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

GEHC vs. The Competition

MetricGE HealthCare TechnologiesHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$29.69B$5.49B$7.25B$13.28B
Dividend Yield0.21%1.77%2.52%22.58%
P/E Ratio15.0825.57275.5926.13
Price / Sales1.4471.28595.2989.84
Price / Cash11.1932.5627.3036.12
Price / Book2.885.9510.586.16
Net Income$2.08B$146.14M$3.50B$381.12M
7 Day PerformanceN/A-0.58%-1.21%-1.43%
1 Month Performance2.83%-2.13%-4.02%-3.36%
1 Year Performance-7.42%5.41%7.17%1.49%

GE HealthCare Technologies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
GEHC
GE HealthCare Technologies
4.0825 of 5 stars
$65.74
flat
$78.52
+19.4%
-7.4%$29.69B$20.63B15.0854,000
PHG
Koninklijke Philips
2.7719 of 5 stars
$23.91
0.0%
N/A-11.5%$23.51B$20.17B17.6265,340
MDT
Medtronic
4.7278 of 5 stars
$88.02
+1.9%
$103.92
+18.1%
-7.3%$110.49B$36.36B21.6895,000
SYK
Stryker
4.9848 of 5 stars
$285.52
+3.7%
$372.64
+30.5%
-24.0%$105.65B$25.12B29.5956,000
BSX
Boston Scientific
4.9029 of 5 stars
$42.40
-0.5%
$67.88
+60.1%
-55.2%$61.74B$20.07B17.1759,000

Related Companies and Tools


This page (NASDAQ:GEHC) was last updated on 10/12/2026 by MarketBeat.com Staff.
From Our Partners